Company Neovasc Inc Toronto S.E.
Equities
CA64065J2056
Advanced Medical Equipment & Technology
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sarah Gallagher
CTO | Chief Tech/Sci/R&D Officer | - | 12/07/21 |
Shmuel Banai
CTO | Chief Tech/Sci/R&D Officer | - | - |
Alexei J. Marko
BRD | Director/Board Member | 56 | 11/06/03 |
Investor Relations Contact | 54 | 01/04/07 | |
Lisa Becker
LAW | General Counsel | - | 12/07/21 |
John Panton
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
CHM | Chairman | 63 | 31/01/08 |
Paul Geyer
BRD | Director/Board Member | 61 | 01/11/00 |
Alexei J. Marko
BRD | Director/Board Member | 56 | 11/06/03 |
Douglas Janzen
BRD | Director/Board Member | 56 | 01/06/05 |
Norman J. Radow
BRD | Director/Board Member | - | 15/09/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,783,553 | 2,556,708 ( 91.85 %) | 0 | 91.85 % |
Company contact information
![address Neovasc Inc](https://cdn.zonebourse.com/static/address/46321427.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.33% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |